Verition Fund Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-132,701
| Closed | -$12.3M | – | 3225 |
|
|
2021
Q4 | $12.3M | Buy |
+132,701
| New | +$8.74M | 0.09% | 138 |
|
|
2021
Q2 | – | Sell |
-2,892
| Closed | -$201K | – | 2302 |
|
|
2021
Q1 | $201K | Buy |
+2,892
| New | +$223K | ﹤0.01% | 1350 |
|
|
2020
Q1 | – | Sell |
-6,469
| Closed | -$294K | – | 1169 |
|
|
2019
Q4 | $294K | Buy |
+6,469
| New | +$306K | 0.01% | 830 |
|
|
2018
Q4 | – | Sell |
-7,437
| Closed | -$342K | – | 1387 |
|
|
2018
Q3 | $342K | Buy |
+7,437
| New | +$301K | 0.01% | 979 |
|
|
2015
Q3 | – | Sell |
-1,382
| Closed | -$64K | – | 781 |
|
|
2015
Q2 | $64K | Buy |
+1,382
| New | +$60K | 0.01% | 576 |
|
|
2015
Q1 | – | Sell |
-2,151
| Closed | -$75K | – | 535 |
|
|
2014
Q4 | $75K | Buy |
2,151
+981
| +84% | +$39.8K | 0.02% | 304 |
|
|
2014
Q3 | $49K | Buy |
+1,170
| New | +$52.2K | 0.01% | 679 |
|
|
2014
Q1 | – | Sell |
-1,479
| Closed | -$87K | – | 675 |
|
|
2013
Q4 | $87K | Buy |
+1,479
| New | +$77.3K | 0.02% | 457 |
|
Verition Fund Management's ARNA Position: Q1 2022 in Review
Verition Fund Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 132,701 shares — an estimated $12.3M sold.
Verition Fund Management first reported a position in ARNA in Q4 2013 and held it in 8 quarters. The position peaked at $12.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Verition Fund Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Verition Fund Management sold 132,701 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $12.3M.
- Verition Fund Management first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 8 quarters.
- Verition Fund Management's Arena Pharmaceuticals Inc position peaked at $12.3M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Verition Fund Management's 13F filing for Q1 2022, filed 13 May 2022.